Hyperphosphatemia and tumor lysis syndrome [5]

Annals of Hematology

Volumn 84, Issue 10, 2005, Pages 696-

  Koduri, Prasad R ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Acute renal failure; Non Hodgkin'slymphoma; Tumor lysis syndrome

Indexed keywords

ANTINEOPLASTIC AGENT; PHOSPHATE; SODIUM CHLORIDE;

ACUTE KIDNEY FAILURE; CANCER CELL; CANCER GRADING; CANCER RISK; CELL PROLIFERATION; DILUTION; HIGH RISK PATIENT; HUMAN; HYDRATION; HYPERPHOSPHATEMIA; LETTER; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; TUMOR LYSIS SYNDROME; UREMIA; URINE FLOW RATE;

HUMANS; KIDNEY FAILURE; LYMPHOMA, NON-HODGKIN; PHOSPHORUS METABOLISM DISORDERS; RENAL DIALYSIS; TUMOR LYSIS SYNDROME;

EID: 27644521945     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-005-1073-x     Document Type: Letter

References (3)

1. Karagiannis A, Tsorlalis I, Kakafika A, Pateinakis P, Perifanis V, Harsoulis F (2005) Acute renal failure due to tumor lysis syndrome in a patient with non-Hodgkin's lymphoma. Ann Hematol 84:343-346 10.1007/ s00277-004-0984-2
2. Cohen LF, Balow JE, Magrath IT, Poplack DG, Ziegler JL (1980) Acute tumor lysis syndrome. A review of 37 patients with Burkitt's lymphoma. Am J Med 68:486-491 10.1016/0002-9343(80)90286-7
3. Tsokos GC, Balow JE, Spiegel RJ, Magrath IT (1981) Renal and metabolic complications of undifferentiated and lymphoblastic lymphomas. Medicine (Balt) 60:218-229 1:STN:280:Bi6C1MnnslQ%3D